Therapeutic segment to dominate the US Sleep Apnea Devices Market

Increasing geriatric population and surge in prevalence of lifestyle disorders is expected to drive the demand for US  sleep apnea devices market for the forecast period.

According to TechSci Research report, United States Sleep Apnea Devices Market By Type (Therapeutic v/s Diagnostic) By End User (Hospitals & Clinics, Homecare, Others) By Company, By Region, Forecast & Opportunities, 2026”, The United States sleep apnea devices market is expected to witness significant growth for the next five years. Sleep apnea is potentially serious sleep disorder in which patients suffer from irregular breathing that is breathing repeatedly starts and stops. People suffering from obesity and hypertension are more likely to witness the sleep apnea disease. Also, the increase in old age population who is more prone to getting affected to sleep apnea are expected to boost the growth of sleep apnea market for the forecast period. Sleep apnea is often associated with occurrence of cardiovascular diseases, hypertension, obesity, and diabetes which is more harmful for the body. Sleep apnea devices are equipment used to manage the sleep apnea and facilitate easy breathing in patients suffering from sleep apnea. Shift in preference of consumers towards telehealth monitoring through mHealth apps is expected to boost the demand for sleep apnea devices market. Men are more prone to be getting affected by sleep apnea than the females and the presence of large patient pool in United States is creating lucrative opportunities for the growth of the sleep apnea devices market. Surge in demand for portable, superior and more efficient sleep apnea devices is expected to boost the market growth for the forecast period.

The COVID-19 outbreak across the world which has been declared as pandemic by World Health Organization has affected countries adversely. Leading authorities in United States imposed lockdown restrictions and released a set of precautionary measures to contain the spread of novel coronavirus. Coronavirus affected patients started suffering from shortness of breath along with coughing and sneezing. United States authorities increased the capacity of hospitals as a greater number of patients were getting affected daily and getting admitted into the hospital facilities. Quarantine and government restrictions resulted in temporary closure of sleep clinics and medical equipment suppliers which led to decline in sales of sleep apnea devices. Demand for CPAP devices took a rise due to their less invasive nature than ventilators. Therefore, the sleep apnea devices market is expected to be impacted positively for the forecast period.

However, stringent regulatory requirements and compliances may create hindrance in the growth of the sleep apnea devices market.  

Browse XX Figures spread through XX  Pages and an in-depth TOC on “US  Sleep Apnea Devices Market”.

https://www.techsciresearch.com/report/united-states-sleep-apnea-devices-market/7482.html

United States sleep apnea devices market is segmented into type, end user, regional distribution, and company. Based on type, market is further bifurcated into therapeutic and diagnostic. The therapeutic segment is expected to account to hold major market share for the forecast period, 2022-2026. Therapeutic devices include oral devices, nasal devices, chin straps and positive airway pressure devices. Launch of technologically advanced devices and increase in awareness about the harmful effects of sleep apnea is fueling the market demand. Supportive government policies to promote the healthcare infrastructure and widen the reach of facilities to every sector of society in form of reimbursement policies is contributing significantly to the sleep apnea devices market growth.

ResMed Inc., Philips Healthcare USA, Fisher & Paykel Healthcare Inc., Nihon Kohden America Inc., Invacare Corporation, Devilbiss Healthcare LLC (Medical Depot, Inc.), GE Healthcare, Natus Medical Incorporated, Somnetics International, Inc., Curative Medical, Inc. are the leading players operating in United States sleep apnea devices market. Manufacturers are increasingly focusing on research and development process to fuel higher growth in the market. To meet evolving customer demand with respect to better efficiency and durability, several sleep apnea devices manufacturers are coming up with their technologically advanced offerings.

Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7482

Customers can also request for 10% free customization on this report.

“Manufacturers are using advanced technologies such as use of new devices capable of signal acquisition and analysis and use of smart phones for disease prevention which are integrated with built-in sensors to enhance comfort and convenience of patients and increase the possibility of sleep monitoring at homes is expected to foster the growth of the sleep apnea devices market. Use of wireless devices whose parameters can be changed remotely through sleep centers to perform continuous positive airway titration and take frequent follow-ups and get regular feedbacks for effective treatment is expected to propel the sleep apnea devices market growth until 2026” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.

United States Sleep Apnea Devices Market By Type (Therapeutic v/s Diagnostic) By End User (Hospitals & Clinics, Homecare, Others) By Company, By Region, Forecast & Opportunities, 2026” has evaluated the future growth potential of United States sleep apnea devices market and provided statistics & information on market size, shares, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in the of United States sleep apnea devices market.

Contact

Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York – 10017

Tel: +1-646-360-1656

Email: [email protected]